This translates to a significant increase of ~16 weeks in the mean survival of tumor-bearing mice from 33.8 weeks for Rb1/p107 DKO to 49.6 weeks for Rb1/p107/Hells TKO (p = 0.0052). The gene discussed is RBL1; the disease is neoplasm.